500
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Reply to “mTOR inhibitor-related pulmonary toxicity; incidence even higher”

, &
Page 1235 | Received 04 Mar 2013, Accepted 08 Mar 2013, Published online: 25 Apr 2013

Figures & data

Figure 1. Relative risk for all grades (a) or high grade (b) pulmonary toxicity in patients treated with mTOR inhibitors compared to controls.

Figure 1. Relative risk for all grades (a) or high grade (b) pulmonary toxicity in patients treated with mTOR inhibitors compared to controls.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.